Dignitana AB (publ) (DIGN.ST)
SEK 2.05
(3.54%)
SEK 2.05
(3.54%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 58.97 Million SEK | -136.9% |
| 2022 | 46.37 Million SEK | 27.54% |
| 2021 | 36.36 Million SEK | 22.39% |
| 2020 | 29.7 Million SEK | 1.95% |
| 2019 | 29.14 Million SEK | -1.74% |
| 2018 | 29.65 Million SEK | 54.21% |
| 2017 | 19.23 Million SEK | 240.73% |
| 2016 | 5.64 Million SEK | 99.58% |
| 2015 | 2.82 Million SEK | -66.21% |
| 2014 | 8.37 Million SEK | 125.24% |
| 2013 | 3.71 Million SEK | 7.4% |
| 2012 | 3.46 Million SEK | 148.38% |
| 2011 | 1.39 Million SEK | -33.16% |
| 2010 | 2.08 Million SEK | 15930.77% |
| 2009 | 13 Thousand SEK | -99.19% |
| 2008 | 1.61 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -10.98 Million SEK | -0.69% |
| 2024 Q1 | 14.97 Million SEK | 467.69% |
| 2023 Q3 | 15.05 Million SEK | 7.76% |
| 2023 FY | -17.11 Million SEK | -136.9% |
| 2023 Q4 | -4.07 Million SEK | -127.06% |
| 2023 Q1 | 14.68 Million SEK | 28.69% |
| 2023 Q2 | 13.96 Million SEK | -4.91% |
| 2022 Q3 | 12.35 Million SEK | -1.79% |
| 2022 Q4 | 11.41 Million SEK | -7.58% |
| 2022 FY | 46.37 Million SEK | 27.54% |
| 2022 Q1 | 10.03 Million SEK | -10.05% |
| 2022 Q2 | 12.57 Million SEK | 25.27% |
| 2021 Q1 | 7.9 Million SEK | 38.67% |
| 2021 Q3 | 7.96 Million SEK | -14.75% |
| 2021 Q4 | 11.15 Million SEK | 40.17% |
| 2021 FY | 36.36 Million SEK | 22.39% |
| 2021 Q2 | 9.33 Million SEK | 18.14% |
| 2020 FY | 29.7 Million SEK | 1.95% |
| 2020 Q1 | 7.39 Million SEK | 9.78% |
| 2020 Q3 | 6.76 Million SEK | -31.27% |
| 2020 Q4 | 5.69 Million SEK | -15.78% |
| 2020 Q2 | 9.84 Million SEK | 33.18% |
| 2019 Q2 | 8.57 Million SEK | 21.2% |
| 2019 Q1 | 7.07 Million SEK | -2.38% |
| 2019 Q3 | 6.75 Million SEK | -21.15% |
| 2019 Q4 | 6.73 Million SEK | -0.35% |
| 2019 FY | 29.14 Million SEK | -1.74% |
| 2018 Q3 | 8.97 Million SEK | 11.54% |
| 2018 Q1 | 5.39 Million SEK | -5.06% |
| 2018 Q2 | 8.04 Million SEK | 49.2% |
| 2018 Q4 | 7.24 Million SEK | -19.26% |
| 2018 FY | 29.65 Million SEK | 54.21% |
| 2017 FY | 19.23 Million SEK | 240.73% |
| 2017 Q4 | 5.67 Million SEK | 33.45% |
| 2017 Q3 | 4.25 Million SEK | -11.66% |
| 2017 Q2 | 4.81 Million SEK | 7.59% |
| 2017 Q1 | 4.47 Million SEK | 72.2% |
| 2016 Q4 | 2.6 Million SEK | 18.74% |
| 2016 Q3 | 2.18 Million SEK | 853.34% |
| 2016 FY | 5.64 Million SEK | 99.58% |
| 2016 Q1 | 620.84 Thousand SEK | 35.94% |
| 2016 Q2 | 229.71 Thousand SEK | -63.0% |
| 2015 Q4 | 456.68 Thousand SEK | 7.54% |
| 2015 FY | 2.82 Million SEK | -66.21% |
| 2015 Q3 | 424.66 Thousand SEK | -39.36% |
| 2015 Q2 | 700.32 Thousand SEK | -43.81% |
| 2015 Q1 | 1.24 Million SEK | -64.3% |
| 2014 Q2 | 3.21 Million SEK | 1929.47% |
| 2014 Q1 | 158.39 Thousand SEK | -85.95% |
| 2014 FY | 8.37 Million SEK | 125.24% |
| 2014 Q4 | 3.49 Million SEK | 131.76% |
| 2014 Q3 | 1.5 Million SEK | -53.15% |
| 2013 Q2 | 703.62 Thousand SEK | -49.6% |
| 2013 Q1 | 1.39 Million SEK | 3121.4% |
| 2013 Q3 | 488.81 Thousand SEK | -30.53% |
| 2013 Q4 | 1.12 Million SEK | 130.66% |
| 2013 FY | 3.71 Million SEK | 7.4% |
| 2012 FY | 3.46 Million SEK | 148.38% |
| 2012 Q1 | 2.57 Million SEK | 116.43% |
| 2012 Q3 | 596.63 Thousand SEK | 21.54% |
| 2012 Q4 | -46.2 Thousand SEK | -107.74% |
| 2012 Q2 | 490.89 Thousand SEK | -80.95% |
| 2011 Q1 | 1.12 Million SEK | 157.54% |
| 2011 Q2 | 218.45 Thousand SEK | -80.61% |
| 2011 FY | 1.39 Million SEK | -33.16% |
| 2011 Q4 | -15.68 Million SEK | -2450.8% |
| 2011 Q3 | 667.01 Thousand SEK | 205.33% |
| 2010 Q1 | 605.19 Thousand SEK | 242.17% |
| 2010 Q2 | 350.24 Thousand SEK | -42.13% |
| 2010 Q4 | -1.95 Million SEK | -163.43% |
| 2010 Q3 | 3.08 Million SEK | 781.09% |
| 2010 FY | 2.08 Million SEK | 15930.77% |
| 2009 Q4 | 176.87 Thousand SEK | 3277.12% |
| 2009 Q2 | -287.94 Thousand SEK | -322.11% |
| 2009 FY | 13 Thousand SEK | -99.19% |
| 2009 Q1 | 129.63 Thousand SEK | 0.0% |
| 2009 Q3 | -5567.00 SEK | 98.07% |
| 2008 FY | 1.61 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -1013.291% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 80.382% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 80.382% |
| Arcoma AB | 11.07 Million SEK | -432.662% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | 57.872% |
| BICO Group AB (publ) | 1.83 Billion SEK | 96.779% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | 76.385% |
| CellaVision AB (publ) | 463.04 Million SEK | 87.264% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -1867.668% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 307.541% |
| C-Rad AB (publ) | 66.01 Million SEK | 10.67% |
| Duearity AB (publ) | -4.17 Million SEK | 1511.465% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 241.079% |
| Getinge AB (publ) | 13.43 Billion SEK | 99.561% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 217.432% |
| Iconovo AB (publ) | 17.57 Million SEK | -235.488% |
| Integrum AB (publ) | 690.56 Thousand SEK | -8439.566% |
| Luxbright AB (publ) | -2.79 Million SEK | 2208.46% |
| Mentice AB (publ) | 236.38 Million SEK | 75.053% |
| OssDsign AB (publ) | 83.64 Million SEK | 29.498% |
| Paxman AB (publ) | 12.61 Million SEK | -367.356% |
| Promimic AB (publ) | 38.51 Million SEK | -53.112% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 216.192% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -267.718% |
| ScandiDos AB (publ) | 47.55 Million SEK | -24.006% |
| Sectra AB (publ) | 557.55 Million SEK | 89.423% |
| Sedana Medical AB (publ) | 108.98 Million SEK | 45.889% |
| Senzime AB (publ) | 8.33 Million SEK | -607.171% |
| SpectraCure AB (publ) | -9.22 Million SEK | 739.391% |
| Stille AB | 132.17 Million SEK | 55.383% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 97.019% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 85.855% |